Doral, Nov. 16, 2017 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC PINK: ETST) ("ETST" or "the Company"), an innovative biotech company that operates in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical, medical device, research and development, announces new improved corporate facility and participates in its first major trade expo during December 1-3.
New HQ
ETST has relocated its corporate facility into the city of Doral centrally located by Miami International Airport and major postal service corporate facilities. ETST’s new two-story corporate facility has six office spaces to accommodate the growing team and a large air-condition warehouse to store ETST’s increasingly high-demand inventory. Not only is the new corporate facility large but, it has been completely remodeled to look and feel like the brand as soon as you walk in.
Office Location: 8000 NW 31st Street, Suite 19, Doral, FL 33122
“Our new corporate facility is finally complete, as we recently alluded to (https://www.globenewswire.com/news-release/2017/10/10/1143709/0/en/Earth-Science-Tech-Inc-Partners-with-Centre-SIDA-Amite-Clinic-to-Commence-Final-Pre-Launch-MSN-2-Human-Research-Study.html). We acquired the space in the beginning of September right before hurricane Irma. Due to Irma, the remodeling took more time than anticipated but, thankfully it is complete and fully operational. We plan on adding photos of our new corporate facility to our site very and encourage investors to come and visit.” Stated, Nickolas S. Tabraue, ETST’s President, Director, & COO.
SOHO EXPO
ETST plans to participate on its first major trade expo, Showing Others Healthy Options Expo (SOHO EXPO) at the GayLord Palms Hotel, Kissimmee, FL opened to qualified industry representatives. The expo is produced by Senpa, a non-profit trade association of retailers, manufacturers, distributors, brokers, educators, practitioners, and service providers that are dedicated to protecting and advancing the natural product industry.
ETST will be stationed booths 425 and 427 positioned in half an island located in the prime sector of the expo. Quarter of the island will be for ETST’s CBD products and the other quarter of the island for ETST’s new wholly owned subsidiary, KannaBidioiD, Inc.’s E-liquid/Sublingual products.
Gabriel Aviles, ETST’s Chief Sales Officer & Director comments, “The Soho expo will be an excellent showing. From my past experience at the show, I have found that it is a great opportunity to gain new accounts throughout U.S. as well as increasing our brand awareness. The Soho Expo is an event in the Health Food industry, that wholesale buyers from all over the U.S. to network with manufacturers and vendors to conduct business. The numbers of attendees can vary between 2,500 up to 3,000 wholesale buyers. Not only will the Soho Expo help with awareness and networking with wholesalers and store owners but, it’s also known to do extremely well with sales. I project sales within the two-day event to be over what ETST generates on a monthly average. I look forward on updating our shareholders after the event.”
About Earth Science Tech, Inc. (ETST): Earth Science Tech has the highest quality, purity, and full spectrum High Grade Hemp CBD (Cannabidiol) Oil on the market. Made using the world's best supercritical CO2 liquid extraction, our CBD Oil is 100% natural and organic. Our research performed alongside the University of Central Oklahoma and DV Biologics laboratory, prove we are the top nutritional and dietary supplement brand for High Grade Hemp CBD Oil.
To learn more and to buy CBD Hemp Oil please visit: www.earthsciencetech.com
View ETST's accomplishments and reports on its High-Grade CBD Hemp Oil: (here)
About Earth Science Pharmaceutical: Earth Science Pharmaceutical, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc (ETST). Earth Science Pharmaceutical is focused on becoming a world leader in the development of low cost, non-invasive diagnostic tools, medical devices, testing processes and vaccines for STIs (Sexually Transmitted Infections and/or Diseases). Earth Science Pharmaceutical CEO, Dr. Michel Aubé, a renowned scientist, is committed to help grow ETST in the medical and pharmaceutical industry.
To learn more please visit: www.Earthsciencepharmaceutical.com
About Cannabis Therapeutics: Cannabis Therapeutics, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc. (ETST). Cannabis Therapeutics, Inc. was formed as an emerging biotechnology company poised to become a world leader in cannabinoid research and development for a broad line of cannabis cannabinoid-based pharmaceuticals, nutraceuticals as well as other products & solutions. Cannabis Therapeutics mission it to help change the healthcare landscape by introducing their proprietary cannabis-cannabinoid based products made for both the pharmaceutical and retail consumer markets worldwide.
To learn more please visit: www.Cannabisthera.com
About KannaBidioiD: KannaBidioid, Inc. is wholly owned subsidiary of Earth Science Tech, Inc. (ETST). KannaBidioid, Inc. is focused in the recreational space to manufacture and distribute vapes/e-liquids and gummy edibles in the recreational space formulated by it's unique Kanna and CBD formula. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhance focus, and help with nicotine addiction based on their properties.
To learn more please visit: www.kannabidioidinc.com
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE: These statements and products have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease. Always check with your physician before starting a new dietary supplement program. The FDA has not evaluated the validity or truthfulness of these claims; therefore, we encourage you to review published researches relating to the benefits and properties of CBD hemp oils and other CBD products.
SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.